These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A guide for drug use in depressive disorders. Raskin A Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190 [No Abstract] [Full Text] [Related]
4. A model for drug use with depressed patients. Raskin A; Boothe H; Schulterbrandt JG; Reatig N; Odle D J Nerv Ment Dis; 1973 Feb; 156(2):130-42. PubMed ID: 4570135 [No Abstract] [Full Text] [Related]
5. Psychopharmacologic validation of atypical depression. Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483 [TBL] [Abstract][Full Text] [Related]
6. An outpatient evaluation of phenelzine and imipramine. Davidson J; Raft D; Pelton S J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Frank JB; Kosten TR; Giller EL; Dan E Am J Psychiatry; 1988 Oct; 145(10):1289-91. PubMed ID: 3048121 [TBL] [Abstract][Full Text] [Related]
8. A comparison of phenelzine and imipramine in depressed inpatients. Davidson JR; McLeod MN; Turnbull CD; Miller RD J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542 [TBL] [Abstract][Full Text] [Related]
9. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression. Hekimian LJ; Gershon S; Floyd A Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165 [No Abstract] [Full Text] [Related]
11. Age-sex differences in response to antidepressant drugs. Raskin A J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465 [No Abstract] [Full Text] [Related]
12. Acetylator status and response to phenelzine in depressed patients. Johnstone EC; Marsh W Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641 [No Abstract] [Full Text] [Related]
13. Current drug therapy for agoraphobia. Ravaris CL Am Fam Physician; 1981 Jan; 23(1):129-31. PubMed ID: 7457310 [TBL] [Abstract][Full Text] [Related]
14. Preclinical-clinical correlation of anti-depressant activity: controlled study of gamfexine and imipramine. Gershon S; Hekimian LJ; Floyd A Curr Ther Res Clin Exp; 1967 Jul; 9(7):349-54. PubMed ID: 4963162 [No Abstract] [Full Text] [Related]
15. A comparison of two antidepressant drugs. Imlah NW; Fahy PT; Harrington JA Psychopharmacologia; 1964 Dec; 6(6):472-4. PubMed ID: 5830964 [No Abstract] [Full Text] [Related]
16. A controlled study of single-dose administration of imipramine pamoate in endogenous depression. Miller WC; Marcotte DB; McCurdy L Curr Ther Res Clin Exp; 1973 Oct; 15(10):700-6. PubMed ID: 4201314 [No Abstract] [Full Text] [Related]
17. Enhancement of imipramine antidepressant activity by thyroid hormone. Prange AJ; Wilson IC; Rabon AM; Lipton MA Am J Psychiatry; 1969 Oct; 126(4):457-69. PubMed ID: 4185164 [No Abstract] [Full Text] [Related]
18. Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. McGrath PJ; Stewart JW; Harrison W; Quitkin FM Psychopharmacol Bull; 1987; 23(1):169-72. PubMed ID: 3602314 [No Abstract] [Full Text] [Related]
19. Ejaculatory impairment from both phenelzine and imipramine, with tinnitus from phenelzine. Glass RM J Clin Psychopharmacol; 1981 May; 1(3):152-4. PubMed ID: 7197693 [No Abstract] [Full Text] [Related]
20. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]